Web monitoring for capturing real-world feedback on drugs
First live demo of PLG’s powerful new AI-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
ProductLife Group (PLG) is to host a webinar on the growing importance of web monitoring as a source of timely, real-world product feedback for drugs companies. The short session, which will take place on 26 April at 2:00PM CET, will include the first live demo of PLG’s powerful new artificial-intelligence-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.
During the webinar, AI experts will explore the unique scope of web forums and public social media channels for monitoring consumers’ real-world experience of life sciences products, and to build up an early picture of potential adverse effects. Although the life sciences industry has long understood the potential for timely insight at large scale offered by web and social media listening, the issue until now has been how to monitor these digital channels in an efficient and reliable way to distil the findings that matter - and to do this in a way that respects people’s privacy
.The session will include a first, exclusive look at PLG inVolv via a live demo of the new artificial-intelligence (AI)-based solution, which meets these important criteria. Crucially, it uses machine learning to adapt to the kinds of findings life sciences organisations are most interested in, so that professionals do not waste time looking at content that isn’t of value.
PLG inVolv, which is provided via a software-as-a-service (SaaS) delivery model and is designed to complement rather than replace existing product vigilance and clinical safety systems, is the result of an exclusive partnership with Volv, a specialist in AI-based social listening technology for life sciences.
The webinar, which will run for half an hour, is open to a limited number of participants to allow enough time for a Q&A session following the demonstration. Commenting on the event, Adam Sherlock, CEO of ProductLife Group, said: “Social listening in life sciences, especially in the context of safety and pharmacovigilance, is a hugely hot topic at the moment. Companies are under increasing pressure to proactively track the impact of their products in the market, and what better way than with the help of machine learning and targeted web and social listening? This webinar is very timely, and we expect the session to be over-subscribed.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance